Dual-time-point [18F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy. - Thunold S; Hernes E; Gyland Mikalsen LT; Farooqi S; Öjlert ÅK; Francis RJ; Nowak AK; Szejniuk WM; Nielsen SS; Cedres S; Perdigo MS; Sørensen JB; et al. (EJNMMI research, 2026)